AVAX is currently trading at $11.00, holding just above the $11.00–$11.50 demand. Momentum indicators remain weak, limiting immediate upside follow-through. A holdAVAX is currently trading at $11.00, holding just above the $11.00–$11.50 demand. Momentum indicators remain weak, limiting immediate upside follow-through. A hold

AVAX Price Analysis: Avalanche Tests $11 Support as Momentum Weakens

2 min read

Avalanche is a layer-one blockchain that focuses on quick finality and scalable smart contracts. AVAX is still highly traded, but the price action over the past couple of weeks suggests caution in the cryptocurrency markets as they are all consolidating.

At press time, the coin is trading at $11.08 with a decline of 7.64% over the past 24 hours.

AVAX Holds $11 Support

According to the Tradingview chart, Avalanche continues to trend to the downside, within a larger downtrend structure that has been in existence since late 2025.

The price is currently consolidating around the $11.00 level, which has acted as short-term support on multiple occasions, and the rejection off of the $13.50 – $14.00 resistance zone shows that sellers are still active during rallies.

The RSI is trading between the low 30s, which indicates low momentum but no confirmed bullish divergence. Although this suggests that selling pressure is slowing down, the fact that there hasn’t been a strong amount of volume expansion means that there has not been any aggressive buying going on yet.

If $11.00 can be held as support, AVAX could stabilize and have an attempt to move towards $13.10; however, if the $11.00 support level is taken out with a daily close, this could expose the initial chart to deeper downside risk.

Source: TradingView

Also Read: Avalanche (AVAX) ETF Goes Live on Nasdaq, Putting $15.50 Level in Focus

Analyst Highlights $11.42 Support

According to crypto analyst Ali Charts, the coin continues to be technically constructive as long as $11.42 is held as support, with a potential rebound back towards $13.10 still in play.

$13.10 is an important confirmation level for any recovery attempt since it lines up with previous horizontal resistance.

In conclusion, the coin is at a technically sensitive level, with price compressing near $11 support.

The zone for support must hold in order for a short-term bullish rebound to occur, even though momentum is weak at this time. Until the coin is back above the higher resistance zones, there is a good possibility that the market will be consolidating, and potential downside risks still exist.

Also Read: Avalanche (AVAX) Nears Key Support Level as Short-Term Momentum Faces Test

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29